10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-123067`
Period End Date	20200930
Filing Date	20201109
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	enzn-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 48 Cash Flow Statement 27 Stockholders Equity 26

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.31M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Deferred stock offering expenses	`DeferredOfferingCosts`	$457.00K	USD	Point-in-time
Deferred stock offering expenses	`DeferredOfferingCosts`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$485.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$56.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.82M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.99M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$485.00K	USD	Point-in-time
Total assets	`Assets`	$5.82M	USD	Point-in-time
Total assets	`Assets`	$6.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$306.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$324.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$348.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$99.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$654.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$423.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2020 and December 31, 2019	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2020 and December 31, 2019	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.69M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.08M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.96M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.05M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.32M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.81M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.82M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.48M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Royalties, net	`RoyaltyRevenueAndMilestones`	$158.00K	USD	3 Qtrs
Royalties, net	`RoyaltyRevenueAndMilestones`	$18.00K	USD	3 Qtrs
Royalties, net	`RoyaltyRevenueAndMilestones`	$2.00K	USD	1 Quarter
Royalties, net	`RoyaltyRevenueAndMilestones`	$8.00K	USD	1 Quarter
Total revenues	`Revenues`	$2.00K	USD	1 Quarter
Total revenues	`Revenues`	$18.00K	USD	3 Qtrs
Total revenues	`Revenues`	$158.00K	USD	3 Qtrs
Total revenues	`Revenues`	$8.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$873.00K	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$901.00K	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$327.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$415.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$901.00K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$873.00K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$327.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$415.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-715.00K	USD	3 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-407.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-883.00K	USD	3 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-325.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-242.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-885.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-236.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-325.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-407.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-717.00K	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	3 Qtrs
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	3 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	3 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	3 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	1 Quarter

Cash Flow Statement 27 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-885.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-717.00K	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-1.05M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-6.89M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$165.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.17M	USD	3 Qtrs
Payment of deferred stock offering expenses	`PaymentsOfStockIssuanceCosts`	$300.00K	USD	3 Qtrs
Payment of deferred stock offering expenses	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	$2.65M	USD	3 Qtrs
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	-	USD	3 Qtrs
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	$2.65M	USD	Point-in-time
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-300.00K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.65M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-135.00K	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.52M	USD	3 Qtrs
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.02M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.31M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.02M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.31M	USD	Point-in-time
Deferred stock offering expenses	`DeferredStockOfferingExpenses`	-	USD	3 Qtrs
Deferred stock offering expenses	`DeferredStockOfferingExpenses`	$157.00K	USD	3 Qtrs
Dividend declared in August 2019; paid in October 2019	`DividendsPayableCurrentAndNoncurrent`	$5.31M	USD	Point-in-time
Dividend declared in August 2019; paid in October 2019	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.81M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-242.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-885.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-236.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-325.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-407.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-717.00K	USD	3 Qtrs
Common stock dividend	`DividendsCommonStockStock`	$2.65M	USD	1 Quarter
Common stock dividend	`DividendsCommonStockStock`	$5.31M	USD	1 Quarter
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.81M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.